Oct 26 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening 32
points lower at 5,828 on Monday, according to financial bookmakers.
* ASTRAZENECA: AstraZeneca Plc AZN.L has resumed the U.S. trial of its
experimental COVID-19 vaccine after approval by regulators, and Johnson &
Johnson JNJ.N is preparing to resume its trial on Monday or Tuesday, the
companies said on Friday. * RIO TINTO: Global miner Rio Tinto RIO.L is seeking court approval to
sell its partner's share of diamonds from a mine in Canada's Northwest
Territories, a filing this week showed, hoping to recover around C$120 million
plus legal fees and other costs. * COCA COLA EUROPEAN PARTNERS: Coca-Cola Amatil Ltd CCL.AX said Coca-Cola
European Partners CCEPC.L offered to buy the Australian bottler for A$9.23
billion ($6.58 billion), in what would be the country's biggest deal this year.
* UK REGULATORS: UK regulators are considering plans to allow banks to start
paying dividends again next year, The Times newspaper reported on Monday.
* GOLD: Gold prices fell to an over one-week low, as the dollar firmed and
talks about the new U.S. coronavirus aid package showed no signs of progress.
* OIL: Oil extended last week's losses, falling nearly 2% as a surge in
COVID-19 infections in the United States and Europe prompted concern over crude
demand, while the prospect of increased supply also hit sentiment. * The UK blue-chip index .FTSE closed 1.3% higher on Friday, boosted by
upbeat Barclays' earnings and rising hopes of a Brexit trade deal before year
end, but the blue-chip FTSE 100 still logged its second weekly decline on
concerns over fresh coronavirus restrictions. UK CORPORATE DIARY:
Kin and Carta Plc KCT.L FY earnings
PZ Cussons Plc PZC.L Trading statement
RPS Group Plc RPS.L Q3 trading statement
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB